{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:57Z","timestamp":1777870437979,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02268-8","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:37:42Z","timestamp":1744727862000},"page":"1785-1795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proenkephalin (PENK): a functional biomarker in chronic kidney diseases \u2013 hope or just a new bystander?"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7966-8836","authenticated-orcid":false,"given":"Wiktoria","family":"Grycuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-3315","authenticated-orcid":false,"given":"Zuzanna","family":"Jakubowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-8171","authenticated-orcid":false,"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"2268_CR1","doi-asserted-by":"publisher","first-page":"205031212412284","DOI":"10.1177\/20503121241228446","volume":"12","author":"KB Bufkin","year":"2024","unstructured":"Bufkin KB, Karim ZA, Silva J (2024) Review of the limitations of current biomarkers in acute kidney injury clinical practices. SAGE Open Med 12:20503121241228450. https:\/\/doi.org\/10.1177\/20503121241228446","journal-title":"SAGE Open Med"},{"key":"2268_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1373\/jalm.2017.023598","volume":"2","author":"R Beunders","year":"2017","unstructured":"Beunders R, Struck J, Wu AHB et al (2017) Proenkephalin (PENK) as a novel biomarker for kidney function. J Appl Lab Med 2:400\u2013412. https:\/\/doi.org\/10.1373\/jalm.2017.023598","journal-title":"J Appl Lab Med"},{"key":"2268_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0024-3205(75)90243-X","volume":"17","author":"HW Kosterlitz","year":"1975","unstructured":"Kosterlitz HW, Hughes J (1975) Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci 17:91\u201396. https:\/\/doi.org\/10.1016\/0024-3205(75)90243-X","journal-title":"Life Sci"},{"key":"2268_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clinbiochem.2018.05.010","volume":"58","author":"LJ Donato","year":"2018","unstructured":"Donato LJ, Meeusen JW, Lieske JC et al (2018) Analytical performance of an immunoassay to measure Proenkephalin. Clin Biochem 58:72\u201377. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.05.010","journal-title":"Clin Biochem"},{"key":"2268_CR5","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.peptides.2006.03.008","volume":"27","author":"A Ernst","year":"2006","unstructured":"Ernst A, K\u00f6hrle J, Bergmann A (2006) Proenkephalin A 119\u2013159, a stable Proenkephalin A precursor fragment identified in human circulation. Peptides 27:1835\u20131840. https:\/\/doi.org\/10.1016\/j.peptides.2006.03.008","journal-title":"Peptides"},{"key":"2268_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12873-019-0283-9","volume":"19","author":"M Rosenqvist","year":"2019","unstructured":"Rosenqvist M, Bronton K, Hartmann O et al (2019) Proenkephalin a 119\u2013159 (penKid)\u2014a novel biomarker for acute kidney injury in sepsis: an observational study. BMC Emerg Med 19:75. https:\/\/doi.org\/10.1186\/s12873-019-0283-9","journal-title":"BMC Emerg Med"},{"key":"2268_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.ekir.2018.08.006","volume":"3","author":"A Hollinger","year":"2018","unstructured":"Hollinger A, Wittebole X, Fran\u00e7ois B et al (2018) Proenkephalin A 119\u2013159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney International Reports 3:1424\u20131433. https:\/\/doi.org\/10.1016\/j.ekir.2018.08.006","journal-title":"Kidney International Reports"},{"key":"2268_CR8","volume-title":"StatPearls","author":"JM Cullen","year":"2024","unstructured":"Cullen JM, Cascella M (2024) Physiology, Enkephalin. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.peptides.2007.11.004","volume":"29","author":"GM Denning","year":"2008","unstructured":"Denning GM, Ackermann LW, Barna TJ et al (2008) Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides 29:83\u201392. https:\/\/doi.org\/10.1016\/j.peptides.2007.11.004","journal-title":"Peptides"},{"key":"2268_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-3565(24)37784-5","volume":"287","author":"SF Sezen","year":"1998","unstructured":"Sezen SF, Kenigs VA, Kapusta DR (1998) Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. J Pharmacol Exp Ther 287:238\u2013245","journal-title":"J Pharmacol Exp Ther"},{"key":"2268_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/SHK.0000000000001510","volume":"54","author":"R Beunders","year":"2020","unstructured":"Beunders R, van Groenendael R, Leijte GP et al (2020) Proenkephalin compared to conventional methods to assess kidney function in critically ill sepsis patients. Shock 54:308\u2013314. https:\/\/doi.org\/10.1097\/SHK.0000000000001510","journal-title":"Shock"},{"key":"2268_CR12","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.ekir.2023.08.006","volume":"8","author":"R Beunders","year":"2023","unstructured":"Beunders R, Donato LJ, Van Groenendael R et al (2023) Assessing GFR With Proenkephalin. Kidney Int Rep 8:2345\u20132355. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.006","journal-title":"Kidney Int Rep"},{"key":"2268_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s00392-019-01424-y","volume":"108","author":"P Kanagala","year":"2019","unstructured":"Kanagala P, Squire IB, On behalf of the GREAT (Global REsearch on Acute Conditions Team) Network et al (2019) Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study. Clin Res Cardiol 108:940\u2013949. https:\/\/doi.org\/10.1007\/s00392-019-01424-y","journal-title":"Clin Res Cardiol"},{"key":"2268_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s40620-014-0163-z","volume":"28","author":"R Marino","year":"2015","unstructured":"Marino R, Struck J, Hartmann O et al (2015) Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. J Nephrol 28:717\u2013724. https:\/\/doi.org\/10.1007\/s40620-014-0163-z","journal-title":"J Nephrol"},{"key":"2268_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/clc.23729","volume":"44","author":"JE Emmens","year":"2021","unstructured":"Emmens JE, Maaten JM, Brouwers FP et al (2021) Proenkephalin and the risk of new-onset heart failure: data from prevention of renal and vascular end-stage disease. Clin Cardiol 44:1662\u20131672. https:\/\/doi.org\/10.1002\/clc.23729","journal-title":"Clin Cardiol"},{"key":"2268_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3343\/alm.2020.40.6.466","volume":"40","author":"H Kim","year":"2020","unstructured":"Kim H, Hur M, Struck J et al (2020) Proenkephalin predicts organ failure, renal replacement therapy, and mortality in patients with sepsis. Ann Lab Med 40:466\u2013473. https:\/\/doi.org\/10.3343\/alm.2020.40.6.466","journal-title":"Ann Lab Med"},{"key":"2268_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12999","volume":"48","author":"T Breidthardt","year":"2018","unstructured":"Breidthardt T, Jaeger C, Christ A et al (2018) Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease. Eur J Clin Invest 48:e12999. https:\/\/doi.org\/10.1111\/eci.12999","journal-title":"Eur J Clin Invest"},{"key":"2268_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jacc.2016.10.038","volume":"69","author":"LL Ng","year":"2017","unstructured":"Ng LL, Squire IB, Jones DJL et al (2017) Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure. J Am Coll Cardiol 69:56\u201369. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.038","journal-title":"J Am Coll Cardiol"},{"key":"2268_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cardfail.2016.09.007","volume":"23","author":"Y Matsue","year":"2017","unstructured":"Matsue Y, Ter Maaten JM, Struck J et al (2017) Clinical correlates and prognostic value of Proenkephalin in acute and chronic heart failure. J Cardiac Fail 23:231\u2013239. https:\/\/doi.org\/10.1016\/j.cardfail.2016.09.007","journal-title":"J Cardiac Fail"},{"key":"2268_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001048","volume":"6","author":"J Molvin","year":"2019","unstructured":"Molvin J, Jujic A, Navarin S et al (2019) Bioactive adrenomedullin, Proenkephalin A and clinical outcomes in an acute heart failure setting. Open Heart 6:e001048. https:\/\/doi.org\/10.1136\/openhrt-2019-001048","journal-title":"Open Heart"},{"key":"2268_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12882-023-03432-7","volume":"25","author":"AL Bullen","year":"2024","unstructured":"Bullen AL, Katz R, Poursadrolah S et al (2024) Plasma Proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. BMC Nephrol 25:16. https:\/\/doi.org\/10.1186\/s12882-023-03432-7","journal-title":"BMC Nephrol"},{"key":"2268_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/1354750X.2018.1443514","volume":"23","author":"LM Kieneker","year":"2018","unstructured":"Kieneker LM, Hartmann O, Bergmann A et al (2018) Proenkephalin and risk of developing chronic kidney disease: the prevention of renal and vascular end-stage disease study. Biomarkers 23:474\u2013482. https:\/\/doi.org\/10.1080\/1354750X.2018.1443514","journal-title":"Biomarkers"},{"key":"2268_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000700","volume":"3","author":"LM Kieneker","year":"2017","unstructured":"Kieneker LM, Hartmann O, Struck J et al (2017) Plasma Proenkephalin and poor long-term outcome in renal transplant recipients. Transpl Direct 3:e190. https:\/\/doi.org\/10.1097\/TXD.0000000000000700","journal-title":"Transpl Direct"},{"key":"2268_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/00365513.2021.1979243","volume":"81","author":"C Nilsson","year":"2021","unstructured":"Nilsson C, Christensson A, Nilsson PM et al (2021) Pro-Enkephalin and its association with renal function in Middle Eastern immigrants and native Swedes. Scand J Clin Lab Invest 81:573\u2013578. https:\/\/doi.org\/10.1080\/00365513.2021.1979243","journal-title":"Scand J Clin Lab Invest"},{"key":"2268_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1515\/cclm-2022-0545","volume":"61","author":"NJL Smeets","year":"2023","unstructured":"Smeets NJL, Hartmann O, Schulte J et al (2023) Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements. Clin Chem Lab Med 61:104\u2013111. https:\/\/doi.org\/10.1515\/cclm-2022-0545","journal-title":"Clin Chem Lab Med"},{"key":"2268_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1681\/ASN.2015101177","volume":"28","author":"C-A Schulz","year":"2017","unstructured":"Schulz C-A, Christensson A, Ericson U et al (2017) High level of fasting plasma Proenkephalin-A predicts deterioration of kidney function and incidence of CKD. JASN 28:291\u2013303. https:\/\/doi.org\/10.1681\/ASN.2015101177","journal-title":"JASN"},{"key":"2268_CR27","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/ijms18081662","volume":"18","author":"J Mossanen","year":"2017","unstructured":"Mossanen J, Pracht J, Jansen T et al (2017) Elevated soluble urokinase plasminogen activator receptor and Proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery. IJMS 18:1662. https:\/\/doi.org\/10.3390\/ijms18081662","journal-title":"IJMS"},{"key":"2268_CR28","doi-asserted-by":"publisher","first-page":"15015","DOI":"10.3390\/ijms241915015","volume":"24","author":"W Grycuk","year":"2023","unstructured":"Grycuk W, Jakubowska Z, Ma\u0142yszko J (2023) Proenkephalin levels and its determinants in patients with end-stage kidney disease treated with hemodialysis and peritoneal dialysis. IJMS 24:15015. https:\/\/doi.org\/10.3390\/ijms241915015","journal-title":"IJMS"},{"key":"2268_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13054-023-04556-w","volume":"27","author":"T Von Groote","year":"2023","unstructured":"Von Groote T, Albert F, Meersch M et al (2023) Evaluation of Proenkephalin A 119\u2013159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury. Crit Care 27:276. https:\/\/doi.org\/10.1186\/s13054-023-04556-w","journal-title":"Crit Care"},{"key":"2268_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2022.e00278","volume":"31","author":"C Lima","year":"2022","unstructured":"Lima C, Gorab DL, Fernandes CR, Macedo E (2022) Role of Proenkephalin in the diagnosis of severe and subclinical acute kidney injury during the perioperative period of liver transplantation. Pract Lab Med 31:e00278. https:\/\/doi.org\/10.1016\/j.plabm.2022.e00278","journal-title":"Pract Lab Med"},{"key":"2268_CR31","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.3390\/ijms252010873","volume":"25","author":"J Tichy","year":"2024","unstructured":"Tichy J, Hausmann A, Lanzerstorfer J et al (2024) Prediction of successful liberation from continuous renal replacement therapy using a novel biomarker in patients with acute kidney injury after cardiac surgery-an observational trial. Int J Mol Sci 25:10873. https:\/\/doi.org\/10.3390\/ijms252010873","journal-title":"Int J Mol Sci"},{"key":"2268_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/OXFORDJOURNALS.NDT.A091480","volume":"1","author":"C Zoccali","year":"1987","unstructured":"Zoccali C, Ciccarelli M, Mallamaci F et al (1987) Plasma met-enkephalin and leu-enkephalin in chronic renal failure. Nephrol Dial Transpl 1:219\u2013222. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.NDT.A091480","journal-title":"Nephrol Dial Transpl"},{"key":"2268_CR33","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3390\/jcm12072474","volume":"12","author":"K Wala-Zieli\u0144ska","year":"2023","unstructured":"Wala-Zieli\u0144ska K, \u015awierczy\u0144ska-Mr\u00f3z K, Krajewski PK et al (2023) Endogenous opioid imbalance as a potential factor involved in the pathogenesis of chronic kidney disease-associated pruritus in dialysis patients. JCM 12:2474. https:\/\/doi.org\/10.3390\/jcm12072474","journal-title":"JCM"},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0923-1811(95)00451-W","volume":"10","author":"K Danno","year":"1995","unstructured":"Danno K, Nishiura K, Tanaka M (1995) Increased met-enkephalin plasma levels in hemodialysis patients with or without pruritus. J Dermatol Sci 10:238\u2013240. https:\/\/doi.org\/10.1016\/0923-1811(95)00451-W","journal-title":"J Dermatol Sci"},{"key":"2268_CR35","first-page":"306","volume":"137","author":"M Klin","year":"1998","unstructured":"Klin M, Waluga M, Rudka R et al (1998) Plasma catecholamines, neuropeptide Y and leucine-enkephalin in uremic patients before and after dialysis during rest and handgrip. Boll Chim Farm 137:306\u2013313","journal-title":"Boll Chim Farm"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02268-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:16Z","timestamp":1777564756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/7\/1785\/8457445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02268-8","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}